• Gilead Sciences Inc., of Foster City, Calif., said it reached an agreement in principle with Teva Pharmaceuticals Industries Ltd., of Jerusalem, settling litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), Gilead's treatment for HIV infection and chronic hepatitis B virus.